Disclosures for "Next Generation Prodrug Troriluzole: Increased Bioavailability of Riluzole with No Food Effect in Healthy Subjects "
-
Ms. Sevinsky has received personal compensation for serving as an employee of Biohaven. Ms. Sevinsky has stock in Biohaven.
-
Dr. Rozakis has nothing to disclose.
-
Ms. Nepomuceno has received personal compensation for serving as an employee of Biohaven. Ms. Nepomuceno has stock in Biohaven.
-
Ms. Malatesta has nothing to disclose.
-
Dr. Awsare has received personal compensation for serving as an employee of Biohaven. Dr. Awsare has stock in Biohaven.
-
Mr. Ashbrenner has received personal compensation for serving as an employee of Biohaven. Mr. Ashbrenner has received personal compensation for serving as an employee of Navitas. Mr. Ashbrenner has stock in Biohaven. An immediate family member of Mr. Ashbrenner has stock in Biohaven.
-
Mr. Kaplita has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Mr. Kaplita has stock in Biohaven Pharmaceuticals.
-
Kimberly Gentile has stock in Biohaven.
-
Dr. Hussey has received personal compensation for serving as an employee of Allucent.
-
Dr. Qureshi has received personal compensation for serving as an employee of Biohaven.
-
Vladimir Coric has received personal compensation for serving as an employee of Biohaven. Vladimir Coric has received personal compensation in the range of $1,000,000+ for serving as an officer or member of the Board of Directors for Bioahven. Vladimir Coric has stock in Biohaven. Vladimir Coric has received intellectual property interests from a discovery or technology relating to health care.
-
Richard Bertz has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Richard Bertz has stock in Biohaven Pharmaceuticals.